47 Matching Annotations
  1. Last 7 days
  2. aacrjournals.org aacrjournals.org
    TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/mct/article/24/11/1685/766863/TUB-040-a-Homogeneous-and-Hydrophilic-NaPi2b
  3. Apr 2026
  4. pubs.acs.org pubs.acs.org
    Dual-Targeting mRNA Cancer Vaccines for Simultaneous Antigen Presentation in Dendritic and Tumor Cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pubs.acs.org/doi/10.1021/acsnano.5c20535
  5. Mar 2026
  6. 54.241.53.176 54.241.53.176
    2026.03.03.709347v1.full-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    54.241.53.176/5bb5b564582bd72829089ab02dde7a8f8136cb33/2026.03.03.709347v1.full-html.html
  7. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Sym024 interacts with a unique epitope on the CD73 homodimer, favoring effective bivalent binding to improve anti-PD1 therapy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12950896/
  8. Jan 2026
  9. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Expanding the payload scope in antibody-drug conjugates by delivery of hydroxy-containing drugs through self-immolative phosphoramidates
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12820277/
  10. Nov 2025
  11. www.sciencedirect.com www.sciencedirect.com
    Development of recombinant Mesozumab-CPTin that dual-targets mesothelin and CP2c for anticancer therapy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S075333222500993X
  12. Sep 2025
  13. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Structure-guided loop grafting improves expression and stability of influenza neuraminidase for vaccine development
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12419796/
  14. Jul 2025
  15. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12304097/
  16. www.sciencedirect.com www.sciencedirect.com
    Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124725007120
  17. May 2025
  18. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12061477/
  19. Apr 2025
  20. www.sciencedirect.com www.sciencedirect.com
    A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124725002700
  21. Mar 2025
  22. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11927390/
  23. Jan 2025
  24. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11771511/
  25. Sep 2024
  26. www.sciencedirect.com www.sciencedirect.com
    Discovery and characterization of a pan-betacoronavirus S2-binding antibody
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0969212624003691
  27. www.sciencedirect.com www.sciencedirect.com
    Dynamic allostery drives autocrine and paracrine TGF-β signaling
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424009656
  28. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11372362/
  29. Jul 2024
  30. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11251093/
  31. Jun 2024
  32. www.sciencedirect.com www.sciencedirect.com
    Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S107476132400253X
  33. Mar 2024
  34. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10963030/
  35. Nov 2023
  36. www.cell.com www.cell.com
    The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell-reports/fulltext/S2211-1247(23)01378-5
  37. Oct 2023
  38. www.science.org www.science.org
    Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    science.org/doi/10.1126/scisignal.abk3516
  39. www.sciencedirect.com www.sciencedirect.com
    Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723012068
  40. Aug 2023
  41. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Preclinical Characterization and Phase 1 Trial Results of INBRX-109, a Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10425732/
  42. Jul 2023
  43. 52.53.155.43 52.53.155.43
    ccr-23-0974-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/56e27762e21f3d334d316ca546c7d609a39dce36/ccr-23-0974-html.html
  44. May 2023
  45. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10203562/
  46. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10157364/
  47. Apr 2023
  48. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10115451/
  49. Jan 2023
  50. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9834171/
  51. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9721160/
  52. Nov 2022
  53. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9576691/
  54. Oct 2022
  55. www.sciencedirect.com www.sciencedirect.com
    Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666634022004081
  56. Apr 2022
  57. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8947961/
  58. Mar 2022
  59. www.sciencedirect.com www.sciencedirect.com
    Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867422002033
  60. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8898742/
  61. www.sciencedirect.com www.sciencedirect.com
    Highly mutated antibodies capable of neutralizing N276 glycan-deficient HIV after a single immunization with an Env trimer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124722002182
  62. Jan 2022
  63. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Structures of activin ligand traps using natural sets of type I and type II TGFβ receptors.
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8718839/
  64. Oct 2021
  65. www.sciencedirect.com www.sciencedirect.com
    Pan-ebolavirus protective therapy by two multifunctional human antibodies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S009286742101165X
  66. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A highly potent antibody effective against SARS-CoV-2 variants of concern
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8452523/
  67. Aug 2021
  68. www.sciencedirect.com www.sciencedirect.com
    Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124721010421
  69. www.sciencedirect.com www.sciencedirect.com
    Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867421008928
  70. May 2021
  71. www.sciencedirect.com www.sciencedirect.com
    Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761321000790
  72. www.sciencedirect.com www.sciencedirect.com
    Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124721004198
  73. Apr 2021
  74. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8049401/
  75. Mar 2021
  76. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC7962591/
  77. Dec 2020
  78. www.sciencedirect.com www.sciencedirect.com
    Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1931312820306247
  79. Sep 2020
  80. www.sciencedirect.com www.sciencedirect.com
    Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S193131282030189X
  81. www.sciencedirect.com www.sciencedirect.com
    Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761320300285